PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Jan-2024 Pistoia Alliance launches freely available IDMP Ontology 1.0, covering all five standards set by ISO The Pistoia Alliance
26-Jan-2024 Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) Epigenomics AG
26-Jan-2024 TRYP THERAPEUTICS AND EXOPHARM LIMITED SECURE PIVOTAL 2 CENT WAIVER FROM ASX Tryp Therapeutics Inc.
26-Jan-2024 Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza Lonza Group AG
26-Jan-2024 SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory SCHOTT Pharma AG & Co. KGaA
26-Jan-2024 Sartorius Stedim Biotech publishes preliminary, unaudited results for fiscal 2023 and provides 2024 guidance as well as new midterm outlook Sartorius Stedim Biotech SA
26-Jan-2024 Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin Lonza Group AG
25-Jan-2024 Cytomos appoints new Commercial and Innovation Officer and Techno-Commercial Adviser: Driving the commercialisation strategy as the company evolves from an R&D to a product-based business Cytomos
25-Jan-2024 Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases Kyowa Kirin
25-Jan-2024 Galen announces exclusive licensing agreement with Almeda Pharmaceuticals AG for new Microtabs Plus product. Galen Limited
24-Jan-2024 Samsung Biologics Reports Fourth Quarter and Fiscal Year 2023 Financial Results Samsung Biologics
24-Jan-2024 LEO Pharma announces positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE) LEO Pharma
24-Jan-2024 LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals LEO Pharma
24-Jan-2024 Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd Olympus
24-Jan-2024 Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 ABIVAX
23-Jan-2024  Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA) UNI-BIO SCIENCE GROUP LIMITED
23-Jan-2024 Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals Eckert & Ziegler Strahlen- und Medizintechnik AG
22-Jan-2024 RApport Global Acquired by ELIQUENT Life Sciences RApport Global
22-Jan-2024 Invitation to the virtual AlsterResearch Healthcare Pop-Up Conference on 23 January 2024 at 1:30 pm M1 Kliniken AG
22-Jan-2024 Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months ABIVAX